Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00123201 · ClinicalTrials.gov registry record · Phase 2
Study to Evaluate the Efficacy and Safety of Dronabinol Metered Dose Inhaler (MDI) in Acute Treatment of Migraine Headache
A Phase 2 study, sponsored by Solvay Pharmaceuticals.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00123201: Completed Phase 2 study, sponsored by Solvay Pharmaceuticals.
NCT00123201 is a Phase 2 study that has completed, run by Solvay Pharmaceuticals. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00123201, a Phase 2 study, has completed, sponsored by Solvay Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
The primary objective of this study is to evaluate the efficacy and safety of dronabinol MDI for the acute treatment of moderate to severe migraine headache.
Interventions
- DRUG Dronabinol MDI
Trial Details
| Field | Value |
|---|---|
| Start Date | 2005-09 |
| Est. Completion | 2007-03 |
| Phase | Phase 2 |
What the finished NCT00123201 record still lists
NCT00123201 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which Dronabinol MDI is the first listed.
NCT00123201 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00123201 about?
NCT00123201 is a clinical study titled "Study to Evaluate the Efficacy and Safety of Dronabinol Metered Dose Inhaler (MDI) in Acute Treatment of Migraine Headache". The primary objective of this study is to evaluate the efficacy and safety of dronabinol MDI for the acute treatment of moderate to severe migraine headache.
What is the current status of trial NCT00123201?
This trial is currently completed. It is a Phase 2 study. The study started on 2005-09. Estimated completion is 2007-03.
What interventions are being tested in trial NCT00123201?
The interventions under investigation include: Dronabinol MDI (DRUG).
Who is sponsoring clinical trial NCT00123201?
This trial is sponsored by Solvay Pharmaceuticals, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia